2019 International Congress » Cognition and Cognitive Disorders

Date: Wednesday, September 25, 2019

Time: 1:15pm-2:45pm

Location: Agora 3 East, Level 3

Meeting: 2019 International Congress

1:15pm-2:45pm: A comparison of serial position effects between patients with MCI due to Parkinson’s disease and patients with MCI due to Alzheimer’s disease

A. Meyer, I. Handabaka, MM. Ehrensperger, U. Gschwandtner, F. Hatz, AU. Monsch, RD. Stieglitz, P. Fuhr (Basel, Switzerland)

1:15pm-2:45pm: Accuracy of the MoCA in Detecting PD-MCI in the Ontario Neurodegenerative Disease Research Initiative study

KB. Zaidi, C. Marras, A. Troyer, A. Lang, M. Masellis, D. Grimes, D. Kwan, JB. Orange, A. Roberts, B. Levine, M. Jog, T. Steeves, B. Tan, P. Mclaughlin (Toronto, ON, Canada)

1:15pm-2:45pm: An external relative to an internal focus of attention enhances motor learning in children with poor motor imagery ability

R. Abdollahipour, M. Bahmani, M. Babak, W. Land (Olomouc, Czech Republic)

1:15pm-2:45pm: Applicability of short form of Montreal Cognitive Assessment to Brazilian Portuguese

M. Olchik, C. Rieder, L. Scudeiro, R. Millette, R. Rech, A. Ayres (Porto Alegre, Brazil)

1:15pm-2:45pm: BODILY AND FACIAL EMOTION RECOGNITION IN PARKINSON´S DISEASE

Z. Kosutzka, P. Brandoburova, I. Straka, V. Veronika, P. Valkovic, M. Hajduk (Bratislava, Slovakia)

1:15pm-2:45pm: Body Representation Impairments in Parkinson’s disease: A Preliminary Report

J. Cardona, C. Martinez, W. Correa, J. Grisales, C. Trujillo, F. Marmolejo-Ramos (Santiago de Cali, Colombia)

1:15pm-2:45pm: Brain amyloid contribution to cognitive dysfunction in Lewy bodies disorders: a pilot study

R. Biundo, E. Fiorenzato, D. Cecchin, C. Salvotti, L. Weis, A. Antonini (Venice, Italy)

1:15pm-2:45pm: Cardiovascular autonomic function and MCI in Parkinson’s disease

CE. Cicero, L. Raciti, R. Monastero, G. Mostile, G. Donzuso, G. Sciacca, A. Luca, C. Terravecchia, L. Giuliano, R. Baschi, M. Davì, M. Zappia, A. Nicoletti (Catania, Italy)

1:15pm-2:45pm: Clinical and neuroimaging heterogeneity of dementia with Lewy bodies

A. Chimagomedova, E. Vasenina, O. Levin (Moscow, Russian Federation)

1:15pm-2:45pm: Clinical, motor and global cognition in patients with in early stages of Parkinson disease

J. Orozco, J. Valderrama, Y. Castaño, J. Arango, A. Navarro, B. Muñoz (Cali, Colombia)

1:15pm-2:45pm: Cognitive ability characterization of rat model with mutated alpha-synuclein overexpression

C. Laloux, C. Lachaud, K. Timmerman, E. Bezard, R. Bordet, D. Devos (Lille, France)

1:15pm-2:45pm: Cognitive complaint in Parkinson’s disease patients with normal cognition: Canary in the coal mine?

R. Purri, L. Brennan, J. Rick, S. Xie, B. Deck, L. Chahine, N. Dahodwala, A. Chen-Plotkin, J. Duda, J. Morley, R. Akhtar, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

1:15pm-2:45pm: Cognitive impairment in Parkinson’s Disease: A cross-sectional association study

A. Simon, C. Rodriguez-Blazquez, MJ. Forjaz, P. Martinez-Martin (Madrid, Spain)

1:15pm-2:45pm: Cognitive impairment profile of patients with Essential Tremor and Parkinson’s Disease

A. Abundes-Corona, A. Cervantes-Arriaga, R. Zerón-Martínez, R. Solís-Vivanco, O. Cárdenas-Saenz, M. Rodríguez-Violante (Mexico City, Mexico)

1:15pm-2:45pm: Cognitive multi-domain assessment in Parkinson’s disease: A more sensitive approach

C. Trujillo, S. Baez, E. Herrera, A. Garcia, A. Ibañez, J. Cardona (Santiago de Cali, Colombia)

1:15pm-2:45pm: Cognitive profile of degenerative parkinsonian syndromes in the French West Indies and relationship with eye movements recordings

A. Petit, A. Lackmy, R. Edragas, S. Belson, A. Mongis-Marlin, C. Stattner, F. Triboulet, G. Lepage, B. Tressieres, B. Gaymard, A. Lannuzel (Fort de France, Martinique)

1:15pm-2:45pm: Cognitive Profile of Patients with Parkinson´s Disease and Subthalamic Nucleus Deep Brain Stimulation

E. Barbosa, J. Santos, H. Fichman (Rio de Janeiro, Brazil)

1:15pm-2:45pm: Cognitive Training in Parkinson’s Disease: Experience in a Rehabilitation Hospital from Brazil

N. Sousa, A. Neri, I. Brandi, S. Brucki (Salvador, Brazil)

1:15pm-2:45pm: Comparing motor and neuropathological features of Parkinson’s disease dementia and dementia with Lewy bodies

D. Hansen, T. Lashley, J. Holton, T. Warner (London, United Kingdom)

1:15pm-2:45pm: Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways

JJ. Hu, T. Wang (Wuhan, China)

1:15pm-2:45pm: Computerized cognitive test profile of 100 patients with and without Amyloid beta 1-42 burden

F. Waga, I. Liepelt-Scarfone, M. Bentele, W. Maetzler, S. Becker, M. Timmers, L. van Nueten, G. Salvadore, K. Brockmann, M. Hobert, J. Streffer, D. Berg (Titusville, NJ, USA)

1:15pm-2:45pm: Correlation between striatal CIT uptake and Mini-Mental State Examination in Parkinson’s disease

OD. Kwon, SG. Park, SB. Lee, JA. Park (Daegu, Republic of Korea)

1:15pm-2:45pm: DBS for Parkinson-Dementia syndrome: Stimulation of both Globus Pallidus internus & the Nucleus Basalis of Meynert using the same electrode lead

C. Nombela, A. Lozano, C. Villanueva-Iza, J. Barcia (Madrid, Spain)

1:15pm-2:45pm: Differential temporal processing across Lewy body disorders and relation to cognitive fluctuations

E. Matar, J. Phillips, K. Ehgoetz Martens, G. Halliday, S. Lewis (Sydney, Australia)

1:15pm-2:45pm: Distinct neuronal correlates underpin impulsive action and impulsive choice in Tourette disorder

C. Atkinson-Clement, A. de Liege, C. Porte, Y. Klein-Koerkamp, B. Beranger, A. Hartmann, Y. Worbe (Paris, France)

1:15pm-2:45pm: Executive functions correlate with DaT-SPECT laterality in Parkinson’s disease

T. Alvarez-Avellon, E. Suarez-San Martin, C. Garcia-Fernandez, J. Alvarez-Carriles, R. Ribacoba, F. Cuetos, M. Menendez-Gonzalez (Oviedo, Spain)

1:15pm-2:45pm: Functional connectivity and microstructural alterations in regions of synaptic density loss in DLB and PDD

T. Yousaf, G. Dervenoulas, G. Pagano, C. Loane, H. Wilson, A. Chandra, O. Cousins, R. Gunn, E. Rabiner, F. Niccolini, M. Esposito, L. Ricciardi, D. Aarsland, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Gait patterns may distinguish Parkinsonian patients with and without mild cognitive impairment: a data mining approach

M. Amboni, C. Ricciardi, C. de Santis, G. Ricciardelli, S. Cuoco, G. Improta, L. Iuppariello, G. Santangelo, M. Cesarelli, P. Barone (Baronissi (salerno), Italy)

1:15pm-2:45pm: Gut microbiota in Parkinson disease with mild cognition impairment in a southern Chinese cohort.

TZ. Ren, K. Nie, LJ. Wang (Guangzhou, China)

1:15pm-2:45pm: Heart Rate Variability and Cognitive Impairment in Parkinson’s Disease

C. Terroba-Chambi, D. Vigo, M. Merello (Caba, Argentina)

1:15pm-2:45pm: Higher probability of prodromal Parkinson’s disease is related to lower performance in all cognitive domains

A. Bougea, M. Maraki, M. Yannakoulia, M. Stamelou, G. Xiromerisiou, M. Kosmidis, E. Dardiotis, G. Hadjigeorgiou, P. Sakka, C. Anastasiou, L. Stefanis, N. Scarmeas (Athens, Greece)

1:15pm-2:45pm: Identifying delirium in people with Parkinson’s disease: the Determine-PD pilot study

R. Lawson, S. Richardson, A. Yarnall, D. Burn, L. Allan (Newcastle Upon Tyne, United Kingdom)

1:15pm-2:45pm: Identifying subtypes of Mild Cognitive Impairment in Parkinson’s disease using cluster analysis

D. Pourzinal, JH. Yang, G. Byrne, J. O'Sullivan, L. Mitchell, K. Mcmahon, D. Copland, N. Dissanayaka (St Lucia, Australia)

1:15pm-2:45pm: Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson’s Disease

A. Martini, L. Weis, E. Fiorenzato, R. Schifano, V. Cianci, A. Antonini, R. Biundo (Newcastle-under-Lyme, United Kingdom)

1:15pm-2:45pm: Impaired colour discrimination is associated with hallucinations in Dementia with Lewy Bodies

E. Matar, K. Ehgoetz Martens, J. Phillips, G. Halliday, S. Lewis (Sydney, Australia)

1:15pm-2:45pm: Impaired fonction of mirror neurons and the role of levodopa in PD patients

T. Danaila, P. Jaulent, C. Laurencin, J. Xie, H. Klinger, P. Krolak-Salmon, S. Thobois (Lyon, France)

1:15pm-2:45pm: Introduction of an Assessment Toolkit Increases the Rate of DLB Diagnosis

A. Surendranathan, J. Kane, A. Bentley, S. Barker, J. Taylor, A. Thomas, I. Mckeith, D. Burn, J. O'Brien (Cambridge, United Kingdom)

1:15pm-2:45pm: Is Dizziness a sign before DLB onset?

M. Matsumura (Tokyo, Japan)

1:15pm-2:45pm: Levodopa Effects on Visuospatial Working Memory in Parkinson’s Disease

E. Bayram, I. Litvan, B. Wright, C. Grembowski, D. Harrington (La Jolla, CA, USA)

1:15pm-2:45pm: Low doses of scopolamine exacerbates dementia among Drosophila with Parkinson’s disease pathophysiology

G. Chandran (Mysore, India)

1:15pm-2:45pm: MCI reverters have a favorable cognitive prognosis and cortical integrity in Parkinson’s disease

SJ. Chung, Y-H. Park, YH. Sohn, J-M. Lee, PH. Lee (Seoul, Republic of Korea)

1:15pm-2:45pm: Measuring cognitive decline in PD-MCI patients with high level education: Do we have the appropriate tools?

L. Mentzer, A. Richardson, T. Nevo, S. Meyer, S. Rosenblum, N. Gemerman, S. Hassin-Baer, S. Israeli-Korn, T. Fay-Karmon, V. Livneh, G. Yahalom (Ramat-Gan, Israel)

1:15pm-2:45pm: Mild Cognitive Impairment in Parkinson’s disease in South Indian population – Development of a test battery and assessment of prevalence and characteristics

S. Krishnan Nair, R. Ramesh, G. Sarma, D. Puthenveedu, R. Menon, A. Kishore (Thiruvananthapuram, India)

1:15pm-2:45pm: Mild Cognitive Impairment in Young Onset Parkinson Disease

A. Troster, C. Schweer (Phoenix, AZ, USA)

1:15pm-2:45pm: Movement disorders spectrum in patients with frontotemporal dementia

YU. Shpilyukova, E. Fedotova, D. Grishina, S. Illarioshkin (Moscow, Russian Federation)

1:15pm-2:45pm: Negative and Positive Feedback Processing in Parkinson’s Disease and Impulse Control Disorder: an ERP Study

A. Martini, R. Schifano, L. Weis, R. Biundo, S. Tamburin, J. Brooks, A. Antonini, G. Leoni, N. Edelstyn (Newcastle-Under-Lyme, United Kingdom)

1:15pm-2:45pm: Neural correlates of Level-1 and Level-2 diagnostic criteria for Mild Cognitive Impairment in Parkinson´s disease.

I. Aracil-Bolaños, F. Sampedro, J. Marín-Lahoz, A. Horta-Barba, S. Martínez-Horta, JM. González-de-Echávarri, J. Pérez-Pérez, H. Bejr-Kasem, B. Pascual-Sedano, MA. Boti, A. Campolongo, C. Izquierdo, A. Gironell, B. Gómez-Ansón, J. Pagonabarraga, J. Kulisevksy (Barcelona, Spain)

1:15pm-2:45pm: Neurocognitive changes after STN-DBS among PD patients – a 2-year follow-up study in Hong Kong

V. Tang, D. Chan, XL. Zhu, D. Chan, C. Lau, A. Chan, K. Ma, J. Yeung, V. Mok, W. Poon (N.t., Hong Kong)

1:15pm-2:45pm: Neurocognitive changes post-bilateral globus pallidus interna DBS for Parkinson’s disease with autologous sural nerve graft to the substantia nigra or nucleus basalis of Meynert

L. Koehl, E. Wallace, J. Quintero, F. Schmitt, C. van Horne (Lexington, KY, USA)

1:15pm-2:45pm: Neuroprotective Effects of Combined Administration of Coenzyme Q10 and Vitamin-E in Chronic Cerebral Hypoperfusion-Induced Neurodegeneration in Rats

WMY. Mohamed, MA. Alazimi (Kuantan, Malaysia)

1:15pm-2:45pm: Neuropsychological changes over the first 6 years of Parkinson’s disease in the ICICLE-PD cohort

R. Lawson, G. Duncan, T. Khoo, D. Breen, M. Camacho, C. Williams-Gray, R. Barker, L. Rochester, D. Burn, A. Yarnall (Newcastle Upon Tyne, United Kingdom)

1:15pm-2:45pm: Neuropsychological differences between patients with Parkinson’s Disease and Essential Tremor

M. Zorn, K. Duff, J. Rolston, C. Aquino, J. Ballard, P. Moretti (Salt Lake City, UT, USA)

1:15pm-2:45pm: Patterns of neuropsychological profiles according to severity of depressive symptoms in newly diagnosed Parkinson’s disease patients

SJ. Kim (Busan, Republic of Korea)

1:15pm-2:45pm: Pisa syndrome in Parkinson’s disease: a study on the neuropsychological profile.

E. Montanaro, CA. Artusi, S. Tuttobene, A. Romagnolo, M. Zibetti, L. Lopiano (Torino, Italy)

1:15pm-2:45pm: Plasma Soluble ST2 (sST2) levels are Higher in Neurodegeneration and Associate with PD Cognition

ASL. Ng, YJ. Tan, ACW. Yong, BYX. Wong, ZH. Lu, SYE. Ng, SKS. Ting, S. Hameed, L. Zeng, N. Kandiah, WL. Au, LCS. Tan (Singapore, Singapore)

1:15pm-2:45pm: Praxis deficits in patients with Parkinson’s disease: A neuropsychological study

E. Rounis, G. Pizzamiglio (Oxford, United Kingdom)

1:15pm-2:45pm: Predicting DRS-2 Total scores from the MoCA

M. Zorn, K. Duff, J. Rolston, J. Ballard, C. Aquino, P. Moretti (Salt Lake City, UT, USA)

1:15pm-2:45pm: Procedural Memory Changes of Parkinson’s Disease Patients Post Participation in Boxing

A. Ghaffar, R. Gallagher, C. Mcleod, A. Leder (Old Westbury, NY, USA)

1:15pm-2:45pm: Prodromal symptoms in clinically diagnosed dementia with Lewy bodies stratified by Lewy body pathology on autopsy

K. Wyman-Chick, D. Weintraub, M. Rosenbloom, L. Erickson, P. Martin, T. Barclay, M. Barrett (Bloomington, MN, USA)

1:15pm-2:45pm: Profile and progression of cognitive deficits in Progressive Supranuclear Palsy, Multiple System Atrophy and Parkinson’s Disease

E. Fiorenzato, A. Antonini, V. Camparini, L. Weis, C. Semenza, R. Biundo (Venice, Italy)

1:15pm-2:45pm: Quantitative EEG measures reflect general cognitive status in Parkinson’s disease

C. Navarro-Roa, M. Rodriguez-Violante, G. Sanchez-Dinorin, A. Cervantes-Arriaga, R. Solis-Vivanco (Mexico City, Mexico)

1:15pm-2:45pm: Relating web-based-visuo-perception to cognition and genetic variability in Parkinson’s disease: interim report

A. Costantini, M. Tan, M. Lo, L. Leyland, H. Morris, R. Weil (London, United Kingdom)

1:15pm-2:45pm: Relationship between cognitive performance and mobility in Parkinson’s disease

A. Amara, K. Wood, A. Joop, R. Memon, J. Pilkington, M. Bamman, C. Hurt (Birmingham, AL, USA)

1:15pm-2:45pm: Relationship between cognitive performance and mobility in patients with Parkinson´s disease: A cross-sectional study

N. Sousa, R. Macedo, S. Brucki (Salvador, Brazil)

1:15pm-2:45pm: Relationship between eye movements during natural reading and basic oculomotor tasks in PD

J. Waldthaler, L. Stock, C. Krüger-Zechlin, L. Timmermann (Marburg, Germany)

1:15pm-2:45pm: Resting-state EEG spectral power in Parkinson’s disease

J. Dalrymple-Alford, R. Shoorangiz, E. Petersen, R. Jones, B. Elias, L. Livingston, I. Kirk, L. Tippett, M. Livingstone, T. Anderson (Christchurch, New Zealand)

1:15pm-2:45pm: Role of Alzheimer’s Disease Genetic Risk Variant rs9331896 in Cognitive Decline in Parkinson’s Disease

T. Tropea, L. Baratta, K. Maddy, M. Guo, J. Rick, V. van Deerlin, J. Trojanowski, D. Weintraub, A. Chen-Plotkin (Philadelphia, PA, USA)

1:15pm-2:45pm: Self-report of cognitive functional abilities is inaccurate in PD-MCI and PDD

S. Holden, L. Medina, A. Simpson, B. Kluger (Aurora, CO, USA)

1:15pm-2:45pm: Semantic fluency impairment and amygdala atrophy are predictive factors for the development of Parkinson’s disease dementia

O. Cousins, G. Pagano, J. Schulz, G. Dervenoulas, H. Wilson, S. Caminiti, S. Polychronis, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Semantic Memory Assessment in Parkinson’s Disease

J. Cardona, F. Marmolejo-Ramos, C. Trujillo, M. Larson (Santiago de Cali, Colombia)

1:15pm-2:45pm: Severe hypomimia in drug naïve Parkinson´s disease patients may predict mild cognitive impairment

C. Gasca-Salas, L. Vela, J. Obeso (Alcorcón, Spain)

1:15pm-2:45pm: Social cognition in Parkinson’s disease

L. Alonso-Recio, C. Merino, P. Martín, JM. Serrrano (Collado Villalba (madrid), Spain)

1:15pm-2:45pm: Specific SLC6A3 variant shows association with better memory in PD patients longitudinally

M. Ramezani, K. Martens, JS. Provost, I. Kathol, Z. Javer, J. Cheetham, E. Yoon, M. Kibreab, T. Hammer, ST. Lang, T. Alrazi, A. Robichaud, JR. Sarna, D. Martino, G. Pfeffer, O. Monchi (Calgary, AB, Canada)

1:15pm-2:45pm: Spoken Language Profiles in Parkinson’s Disease: A Potential ‘Biomarker’ of Cognitive Change?

A. Roberts (Evanston, IL, USA)

1:15pm-2:45pm: Spontaneous Pisa Syndrome in a Patient with Early-onset Alzheimer’s Disease

KA. Woo, D. Yoo, JY. Lee (Seoul, Republic of Korea)

1:15pm-2:45pm: Synuclein-alpha´s variant, rs 894280 shows association with memory and attention in PD patients

O. Monchi, JR. Sarna, D. Martino, Z. Gan-Or, JA. Ruskey, T. Alrazi, A. Robichaud, T. Hammer, ST. Lang, J. Cheetham, E. Yoon, M. Kibreab, I. Kathol, JS. Provost, M. Ramezani (Calgary, AB, Canada)

1:15pm-2:45pm: Task difficulty and the three-stimulus oddball task in patients with PD

E. Peterson, R. Shoorangiz, R. Jones, L. Livingston, I. Kirk, L. Tippett, M. Livingstone, R. Kuijer, T. Anderson, J. Dalrymple-Alford, B. Elias (Auckland, New Zealand)

1:15pm-2:45pm: Tau pathology is associated to cognitive and not motor function in Parkinson’s disease

I. Liepelt-Scarfone, H. Vanderstichele, W. Maetzler, C. Francois, C. Schulte, M. Timmers, L. van Nueten, G. Salvadore, K. Brockmann, T. Gasser, J. Streffer, E. Stoops, D. Berg (Tübingen, Germany)

1:15pm-2:45pm: The Association between Cognition and Balance in idiopathic Parkinson’s Disease

SH. Jung, L. King, M. Mancini, P. Carlson-Kuhta, R. Morris, J. Nutt, F. Horak (Seoul, Republic of Korea)

1:15pm-2:45pm: The cognitive profile associated with mild parkinsonian signs in a British Birth Cohort at age 69-71

S. Buchanan, C. Lane, K. Lu, T. Parker, S. James, A. Keshavan, S. Keuss, H. Murray-Smith, A. Wong, D. Cash, W. Coath, S. Crutch, N. Fox, M. Richards, A. Schrag, J. Schott (London, United Kingdom)

1:15pm-2:45pm: The comparison of cognitive function between normal and abnormal FDG-PET in non-demented Parkinson’s disease

SJ. Kim, EJ. Chung (Busan, Republic of Korea)

1:15pm-2:45pm: The Effects of Time-Varying Caloric Vestibular Stimulation Therapy on Cognition Impairment in Parkinson’s Disease

K. Ade, A. Podlewska, S. Banducci, T. Pellat-Higgins, M. Bodani, M. Sakel, L. Smith, D. Attix, P. Lewitt, D. Wilkinson (Raleigh, NC, USA)

1:15pm-2:45pm: The interplay between cholinergic activity, attention, and turning in Parkinson’s disease

R. Morris, D. Martini, G. Mcbarron, M. Mancini, F. Horak (Portland, OR, USA)

1:15pm-2:45pm: The P3a wave and cognitive decline in relation to Parkinson’s disease severity

G. Sánchez Dinorín, M. Rodríguez Violante, A. Cervantes Arriaga, C. Navarro Roa, R. Solís Vivanco (Mexico City, Mexico)

1:15pm-2:45pm: The Promise of Automation: Development and preliminary testing of a language-based machine learning algorithm in PD

B. Fujii, R. Richter, A. Roberts (Evanston, IL, USA)

1:15pm-2:45pm: The utility of DCTclock™ (the digital clock drawing test) for unmasking early cognitive decline in Parkinson’s disease

T. Schejter Margalit, R. Kizony, B. Cohen, A. Thaler, W. Souillard-Mandar, A. Holway, V. Irzhevsky, A. Orr-Urtreger, J. Cederbaum, N. Giladi, A. Mirelman (Tel Aviv, Israel)

1:15pm-2:45pm: Using Brain Atrophy and Visual Dysfunction to Predict Dementia in Parkinson’s Disease

L-A. Leyland, R. Mahmood, R. Weil (London, United Kingdom)

1:15pm-2:45pm: Validation of a novel quotient differentiating cognitive and motor-driven activity of daily living impairments in PD patients

S. Becker, C. Pauly, M. Lawton, G. Hipp, F. Bowring, P. Sulzer, M. Hu, R. Krüger, I. Liepelt-Scarfone (Tübingen, Germany)

1:15pm-2:45pm: Validation of the Seoul-instrumental activity daily living in the detection of dementia in Parkinson disease

SJ. Kim (Busan, Republic of Korea)

1:15pm-2:45pm: Vascular risk factors, WMLs and the risk of cognitive impairment in Parkinson disease: A longitudinal study from the Parkinson’s Disease Cognitive Impairment Study (PaCoS) cohort

A. Luca, R. Monastero, G. Donzuso, R. Baschi, C. Cicero, C. Terravecchia, A. Salerno, M. Zuccarello, M. Davì, V. Restivo, G. Mostile, M. Zappia, A. Nicoletti (Catania, Italy)

1:15pm-2:45pm: Vascular white matter involvement in Idiopathic Normal Pressure Hydrocephalus: association with cognitive and motor impairment

M. Todisco, P. Vitali, B. Minafra, F. Avantaggiato, R. Zangaglia, NG. Pozzi, R. Ceravolo, C. Pacchetti (Pavia, Italy)

1:15pm-2:45pm: Verbal Disfluencies in Parkinson´s Disease Spoken Discourse as a Function of Syntax Complexity

S. Gutierrez, K. Aveni, A. Torani, A. Roberts (Evanston, IL, USA)

1:15pm-2:45pm: Visual dysfunction and retinal thinning predict dementia risk in Parkinson’s disease

L-A. Leyland, F. Bremner, R. Mahmood, S. Hewitt, M. Durteste, M. Cartlidge, M. Lai, L. Miller, A. Saygin, P. Keane, A. Schrag, R. Weil (London, United Kingdom)

1:15pm-2:45pm: Visual hallucinations in Lewy Body Disease are characterised by impaired sensory integration

A. Zarkali, R. Adams, L. Leyland, G. Rees, R. Weil (London, United Kingdom)

1:15pm-2:45pm: Visual hallucinations in Parkinson´s disease and amyloid burden: 18F-Flutemetamol PET-MRI study

B. Fernández-Rodríguez, C. Gasca-Salas, R. Rodríguez-Rojas, P. Guida, D. Mata-Marín, I. Obeso-Martín, L. Vela, M. Garcerant-Tafur, L. García-Cañamaque, JA. Obeso (Móstoles, Spain)

1:15pm-2:45pm: Visuoperceptual impairment: a key feature in the diagnosis of corticobasal degeneration

R. Bruffaerts, K. van Bouwel, PH. van Damme, K. Claeys, K. van Laere (Leuven, Belgium)

1:15pm-2:45pm: Visuospatial dysfunction correlates with severity of postural instability/gait disturbance symptoms in parkinson’s disease

H. Jeong, H. Kang (Changwon, Republic of Korea)

« View all sessions from the 2019 International Congress.